Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Clinical trial NCT00068146 · COMPLETED
Trial details
- NCT number
- NCT00068146
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2002-09-19
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.